Tevogen Bio (TVGN) Competitors $1.07 -0.06 (-5.31%) (As of 03:02 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TVGN vs. TECX, TRML, TSHA, GLUE, EXAI, SANA, PROK, HUMA, ALLO, and MGTXShould you be buying Tevogen Bio stock or one of its competitors? The main competitors of Tevogen Bio include Tectonic Therapeutic (TECX), Tourmaline Bio (TRML), Taysha Gene Therapies (TSHA), Monte Rosa Therapeutics (GLUE), Exscientia (EXAI), Sana Biotechnology (SANA), ProKidney (PROK), Humacyte (HUMA), Allogene Therapeutics (ALLO), and MeiraGTx (MGTX). These companies are all part of the "biological products, except diagnostic" industry. Tevogen Bio vs. Tectonic Therapeutic Tourmaline Bio Taysha Gene Therapies Monte Rosa Therapeutics Exscientia Sana Biotechnology ProKidney Humacyte Allogene Therapeutics MeiraGTx Tectonic Therapeutic (NASDAQ:TECX) and Tevogen Bio (NASDAQ:TVGN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings, community ranking and dividends. Does the MarketBeat Community believe in TECX or TVGN? Tectonic Therapeutic received 6 more outperform votes than Tevogen Bio when rated by MarketBeat users. CompanyUnderperformOutperformTectonic TherapeuticOutperform Votes7100.00% Underperform VotesNo VotesTevogen BioOutperform Votes1100.00% Underperform VotesNo Votes Which has better earnings & valuation, TECX or TVGN? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTectonic TherapeuticN/AN/A$12.16M-$5.89-8.84Tevogen BioN/AN/A-$70KN/AN/A Do analysts prefer TECX or TVGN? Tectonic Therapeutic currently has a consensus price target of $72.25, suggesting a potential upside of 38.76%. Tevogen Bio has a consensus price target of $4.20, suggesting a potential upside of 292.52%. Given Tevogen Bio's higher probable upside, analysts plainly believe Tevogen Bio is more favorable than Tectonic Therapeutic.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tectonic Therapeutic 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17Tevogen Bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is TECX or TVGN more profitable? Tectonic Therapeutic's return on equity of -35.53% beat Tevogen Bio's return on equity.Company Net Margins Return on Equity Return on Assets Tectonic TherapeuticN/A -35.53% -31.97% Tevogen Bio N/A -396.07%749.97% Does the media favor TECX or TVGN? In the previous week, Tectonic Therapeutic had 3 more articles in the media than Tevogen Bio. MarketBeat recorded 4 mentions for Tectonic Therapeutic and 1 mentions for Tevogen Bio. Tectonic Therapeutic's average media sentiment score of 1.18 beat Tevogen Bio's score of 0.00 indicating that Tectonic Therapeutic is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tectonic Therapeutic 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tevogen Bio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders have more ownership in TECX or TVGN? 62.6% of Tectonic Therapeutic shares are held by institutional investors. 9.2% of Tectonic Therapeutic shares are held by insiders. Comparatively, 56.6% of Tevogen Bio shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, TECX or TVGN? Tectonic Therapeutic has a beta of 2.6, suggesting that its stock price is 160% more volatile than the S&P 500. Comparatively, Tevogen Bio has a beta of -1.36, suggesting that its stock price is 236% less volatile than the S&P 500. SummaryTectonic Therapeutic beats Tevogen Bio on 10 of the 13 factors compared between the two stocks. Ad TradingTips3 Under-$10 Stocks That Could SkyrocketLooking for affordable stocks that could deliver big returns? Our latest report showcases 3 buy-rated stocks under $10 that analysts believe have major upside potential. Don’t miss out on these hidden opportunities that could boost your portfolio.Download Your Free Report Today. Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TVGN vs. The Competition Export to ExcelMetricTevogen BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$187.31M$3.05B$5.21B$9.15BDividend YieldN/A1.85%5.73%4.02%P/E RatioN/A23.50103.2414.99Price / SalesN/A291.571,247.4687.66Price / CashN/A175.5941.6838.06Price / Book-0.973.944.734.93Net Income-$70,000.00-$41.66M$119.24M$224.48M7 Day Performance-21.90%-1.01%2.33%1.69%1 Month Performance-37.79%-1.50%1.88%8.93%1 Year PerformanceN/A35.49%31.96%28.19% Tevogen Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TVGNTevogen Bio3.7429 of 5 stars$1.07-5.3%$4.20+292.5%N/A$187.31MN/A0.0017TECXTectonic Therapeutic3.4964 of 5 stars$49.62-0.3%$72.25+45.6%N/A$732.04MN/A-8.45120TRMLTourmaline Bio2.2252 of 5 stars$25.46-2.2%$65.00+155.3%+34.7%$652.79MN/A-9.1344Positive NewsTSHATaysha Gene Therapies4.0373 of 5 stars$3.17-2.2%$6.63+109.0%+34.6%$649.67M$9.92M5.14180Positive NewsGap DownGLUEMonte Rosa Therapeutics2.321 of 5 stars$10.35-0.1%$16.00+54.6%+200.0%$635.87M$14.98M-5.7190EXAIExscientia2.6354 of 5 stars$4.84+3.2%$7.00+44.6%-21.7%$632.93M$25.60M-3.21280Positive NewsHigh Trading VolumeSANASana Biotechnology2.5826 of 5 stars$2.77-0.4%$13.50+387.4%-36.2%$618.46MN/A-1.91328PROKProKidney1.8722 of 5 stars$2.10+4.8%$4.50+114.8%+32.2%$611.03MN/A-3.643HUMAHumacyte3.6333 of 5 stars$4.47-1.1%$13.00+190.8%+69.7%$562.59M$1.57M-3.37150Short Interest ↑Gap UpALLOAllogene Therapeutics2.6054 of 5 stars$2.54+2.4%$9.73+283.2%-11.7%$532.57M$43,000.00-1.59232Short Interest ↓Gap DownMGTXMeiraGTx4.6087 of 5 stars$6.71-0.9%$23.50+250.2%+20.3%$524.39M$14.02M-5.60300Positive News Related Companies and Tools Related Companies Tectonic Therapeutic Competitors Tourmaline Bio Competitors Taysha Gene Therapies Competitors Monte Rosa Therapeutics Competitors Exscientia Competitors Sana Biotechnology Competitors ProKidney Competitors Humacyte Competitors Allogene Therapeutics Competitors MeiraGTx Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TVGN) was last updated on 12/5/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tevogen Bio Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tevogen Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TVGN Stock Alerts